Last updated: 11/07/2018 04:37:28
Drug Use Investigation for ADOAIR (fluticasone/salmeterol)
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: Drug Use Investigation for ADOAIR (fluticasone/salmeterol)
Trial description: The purpose of this post-marketing surveillance is to detect adverse drug reactions (particularly clinically significant adverse drug reactions) occurring in clinical settings, to examine factors likely to affect the safety and efficacy in the Japanese asthma patients treated with fluticasone propionate and salmeterol xinafoate.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
The number of incidence of adverse events in Japanese asthma patients treated with fluticasone propionate and salmeterol xinafoate
Timeframe: 6 months
Secondary outcomes:
Not applicable
Interventions:
Drug: Salmeterol and Fluticasone
Enrollment:
2116
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Prospective
Clinical publications:
Takeshi Fukuda, Mihoko Yabuuchi, Yoriko Morioka, Terufumi Hara.Drug Use Investigation of Salmeterol Xinafoate / Fluticasone Propionate Dry Powder Inhalers (Adoair®Diskus®) for Bronchial Asthma (Final Report).Allergol Immunol.2013;20(1):140-157.
Medical condition
Respiratory Disorders
Product
fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
Collaborators
Not applicable
Study date(s)
October 2007 to January 2012
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
Not applicable+ years
Accepts healthy volunteers
None
- Must use fluticasone and salmeterol for the first time
- Patients with hypersensitivity to salmeterol and fluticasone
- Patients with infection which salmeterol and fluticasone is not effective
Inclusion and exclusion criteria
Inclusion criteria:
- Must use fluticasone and salmeterol for the first time
Exclusion criteria:
- Patients with hypersensitivity to salmeterol and fluticasone
- Patients with infection which salmeterol and fluticasone is not effective
- Patients with deep mycosis
Trial location(s)
No location data available.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2012-20-01
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website